Protech Mitra Perkasa Stock Cash And Equivalents
| OASA Stock | IDR 130.00 3.00 2.26% |
Protech Mitra Perkasa fundamentals help investors to digest information that contributes to Protech Mitra's financial success or failures. It also enables traders to predict the movement of Protech Stock. The fundamental analysis module provides a way to measure Protech Mitra's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Protech Mitra stock.
Protech |
Protech Mitra Perkasa Company Cash And Equivalents Analysis
Protech Mitra's Cash or Cash Equivalents are the most liquid of all assets found on the company's balance sheet. It is used in calculating many of the firm's liquidity ratios and is a good indicator of the overall financial health of a company. Companies with a lot of cash are usually attractive takeover targets. Cash Equivalents are balance sheet items that are typically reported using currency printed on notes.
Current Protech Mitra Cash And Equivalents | 13.04 B |
Most of Protech Mitra's fundamental indicators, such as Cash And Equivalents, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Protech Mitra Perkasa is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Cash equivalents represent current assets that are easily convertible to cash such as short term bonds, savings account, money market funds, or certificate of deposits (CDs). One of the important consideration companies make when classifying assets as cash equivalent is that investments they report on their balance sheets under current assets should have almost no risk of change in value over the next few months (usually three months).
| Competition |
In accordance with the recently published financial statements, Protech Mitra Perkasa has 13.04 B in Cash And Equivalents. This is much higher than that of the Construction & Engineering sector and significantly higher than that of the Industrials industry. The cash and equivalents for all Indonesia stocks is notably lower than that of the firm.
Did you try this?
Run Pair Correlation Now
Pair CorrelationCompare performance and examine fundamental relationship between any two equity instruments |
| All Next | Launch Module |
Protech Fundamentals
| Return On Equity | -0.11 | |||
| Return On Asset | -0.0885 | |||
| Operating Margin | (7.50) % | |||
| Current Valuation | 25.42 B | |||
| Shares Outstanding | 6.35 B | |||
| Shares Owned By Insiders | 3.45 % | |||
| Price To Sales | 1,795 X | |||
| Revenue | 3.41 B | |||
| Gross Profit | 1.26 B | |||
| EBITDA | (6.61 B) | |||
| Net Income | 1.3 B | |||
| Cash And Equivalents | 13.04 B | |||
| Book Value Per Share | 118.93 X | |||
| Cash Flow From Operations | 1.28 B | |||
| Earnings Per Share | 3.63 X | |||
| Beta | -0.0677 | |||
| Market Capitalization | 748.97 B | |||
| Total Asset | 47.87 B | |||
| Net Asset | 47.87 B |
About Protech Mitra Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Protech Mitra Perkasa's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Protech Mitra using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Protech Mitra Perkasa based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectOther Information on Investing in Protech Stock
Protech Mitra financial ratios help investors to determine whether Protech Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Protech with respect to the benefits of owning Protech Mitra security.